SomaLogic was founded in 2000 by Larry Gold, with the long-term goal of transforming health care by empowering individuals around the world to actively optimize and maintain their health. Although the first draft of the human genome was also announced that year, SomaLogic embarked on a different path than everyone else, focusing instead on the much harder challenge of measuring changes in the body’s proteins in relation to disease and health. We believed then — and know today — that wide and deep protein measurement can move the idea of precision health from rhetoric to reality.
It took almost two decades of innovative research and investment to reach that goal, but today SomaLogic operates the SomaScan® Platform, a new technology that makes protein measurement as straightforward as DNA measurement. With the SomaScan Platform, SomaLogic uniquely uncovers a deeper understanding of the real-time molecular bases of health and disease than is possible through genomic or other protein technologies.
From these complex protein measurements, we computationally extract meaningful and precise health information, which we can offer to individuals and their health providers in the form of a growing menu of SomaSignal™ tests. The first set of SomaSignal tests are now available only through select physician practices in the Denver, Colorado area, but we are working on expanding both the number of tests and the number of providers over the coming months. Please contact us for more information.
Today, SomaLogic has approximately 200 employees worldwide. It is headquartered in Boulder, Colorado.
SomaLogic’s logo is inspired by the first solved crystal structure of one of our proprietary Slow Off-rate Modified Aptamer (SOMAmer®) reagents binding its target protein.
The elegant binding of the SOMAmer reagent to its target protein includes a variety of unexpected interactions, among which was the insertion of the hexagonal “benzyl group” from one of the modified nucleotides from the SOMAmer reagent into a pocket of the protein (zoomed view is shown in image to the right).
Our logomark (far right) is a designer’s take on that molecular interaction, and underlines the importance of measuring the real-time biology of proteins to deeply understand health and disease.